PPT-MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD)
Author : olivia-moreira | Published Date : 2019-10-31
MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder OUD Opioid Use Disorder OUD A medical condition characterized by a problematic pattern
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "MAT BASICS Peter Mason MD Medical Direct..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD): Transcript
MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder OUD Opioid Use Disorder OUD A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. Presented by:. NJATOD Officers. Barbara . Schlichting. , NJATOD Secretary, Somerset Treatment Services . Christie . Hanvey. , NJATOD Vice President, Spectrum Healthcare Center. . Maiysha. Ware, NJATOD President, The . Lawton . Robert . Burns, Ph.D., MBA. The James . Joo. -Jin Kim Professor. Dept. . of Health Care Management. The Wharton School. burnsL@wharton.upenn.edu. Presentation to FTC/DOJ Competition Workshop. Welcome. Thank you for joining us for our 1. st. AIM Opioid Webinar. Housekeeping:. Session is being recorded. Session will be posted under the opioid section of the AIM website: . https://safehealthcareforeverywoman.org/national-collaborative-on-maternal-oud/. Opioid . Use . Disorder: . The AIM Bundle. Ronald E Iverson, Jr., MD, MPH. Vice-Chair, Obstetrics, Boston Medical Center. Director, Quality Improvement, OBGYN, Boston Medical Center. Assistant Professor, Boston . Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. Engaging Individuals with an Opioid Use Disorder (OUD) David Loveland, Ph.D. Community Care © 2017 Community Care Behavioral Health Organization Questions to Consider 1 2 Could you effectively engage individuals with an OUD in treatment soon after they had recovered from an overdose and could you do it for as low as $5.00 a day? Medication Assisted Treatment (MAT) & Overdose Prevention. Michael Baca-Atlas, MD. Addiction Medicine . Fellow. UNC . School of . Medicine. June 14, 2019. Disclosures. The presenter has nothing to . Opioid use disorder (OUD) is a complex issue that can occur at any time in one’s life and presents differently for everyone. If you suspect that your patient may be at risk of struggling with OUD, Joshua Blum MD. April 7, 2018. No relevant financial disclosures. Learning objectives. Utilize the latest evidence around opioid-induced hyperalgesia to mitigate negative consequences . Implement best practices around opioid rotation to manage OIH. Peggy Compton, PhD, RN, FAAN. Associate Professor. van . Ameringen. Endowed Chair. Department of Family and Community Health. University of Pennsylvania School of Nursing. Betty Ford Award Plenary. www.hivguidelines.org. JANUARY 2021. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase the number of clinicians in outpatient settings offering evidence-based treatment to individuals with opioid use disorder.. Populations:. Best . Practices . . Dr. Chanda Brown. Director, Charleston Center. cfbrown@charlestoncounty.org. Agenda. We Have an Epidemic!. Criminal justice populations. What Are Opioids and Opioid Use Disorder? . This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.. Research . designs, methods, and study execution . Michael C. Rowbotham, MD. Chief Research Officer, Sutter Health. Adjunct Professor, UCSF Anesthesia. Professor Emeritus, UCSF Neurology. What does ‘opioid sparing’ mean and what are the...
Download Document
Here is the link to download the presentation.
"MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
